Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

Polyethylene alanine caused hair loss in young lab animals but not in adults, with hair regrowth occurring within 20 days.

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

Body hair transplantation is an effective method for restoring hair in people with severe baldness and limited scalp donor hair.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Phototherapy is often used for psoriasis in children, but it has low success rates.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

The combination therapy was effective and well-tolerated, especially in young patients.